Responding to FDA 483 CAPA Requests

Developing Effective CAPA Plans After an FDA 483

This article addresses best practices for developing a corrective and preventive action (CAPA) plan following an FDA 483. A well-designed CAPA system should identify the root cause of nonconformances, system failures, or process problems, implement appropriate corrections and corrective actions, and establish measures to prevent recurrence. The resulting investigation and actions should be thoroughly documented and support both regulatory compliance and continuous improvement.

The article emphasizes the importance of timely and complete responses to FDA observations. Each observation should be addressed as a separate CAPA, with the response documenting the investigation, root cause, containment measures, corrections, planned corrective actions, and expected completion dates. Actions already completed at the time of submission should also be supported with appropriate documentation.

FDA may continue to evaluate a company’s response after the initial submission, and a lack of immediate feedback should not be interpreted as acceptance. Companies should follow up with evidence demonstrating completed corrective actions and verification of effectiveness. If FDA determines that a CAPA response is incomplete, additional actions may be requested. An objective review by an experienced third party can help ensure that the response addresses the cited observations comprehensively and that proposed actions are practical and appropriately implemented.

Read the full article: Responding to FDA CAPA Requests